tiprankstipranks
Redx Pharma PLC (GB:REDX)
LSE:REDX

Redx Pharma (REDX) Income Statement

1 Followers

Redx Pharma Income Statement

Last quarter (Q4 2022), Redx Pharma's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, Redx Pharma's net income was £―. See Redx Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Sep 22Sep 21Sep 20Sep 19
Total Revenue
-£ 18.69M£ 18.69M£ 10.04M£ 5.68M£ 3.13M
Cost of Revenue
----£ 0.00£ 350.00K
Gross Profit
-£ 18.69M--£ 5.68M£ 2.78M
Operating Expense
-£ 38.52M£ 37.25M£ 29.82M£ 14.01M£ 9.96M
Operating Income
-£ -19.83M£ -18.56M£ -19.78M£ -8.32M£ -7.18M
Net Non Operating Interest Income Expense
-£ -1.73M£ -1.54M£ -1.70M£ -967.00K£ -90.00K
Other Income Expense
-£ -1.45M----
Pretax Income
-£ -17.80M£ -17.80M£ -21.44M£ -9.17M£ -6.33M
Tax Provision
-£ 201.00K£ 201.00K£ 133.00K£ 45.00K£ -2.02M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-£ -18.00M£ -18.00M£ -21.58M£ -9.21M£ -4.32M
Basic EPS
-£ -0.06£ -0.06£ -0.08£ -0.05£ -0.03
Diluted EPS
-£ -0.06£ -0.06£ -0.08£ -0.05£ -0.03
Basic Average Shares
-£ 294.18M£ 294.18M£ 256.43M£ 170.14M£ 126.51M
Diluted Average Shares
-£ 294.18M£ 294.18M£ 256.43M£ 170.14M£ 126.51M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----£ 0.00£ 389.00K
Total Expenses
-£ 38.52M£ 37.25M£ 29.82M£ 14.01M£ 10.31M
Net Income From Continuing And Discontinued Operation
-£ -18.00M£ -18.00M£ -21.58M£ -9.21M£ -4.32M
Normalized Income
-£ -14.42M£ -18.00M£ -21.58M£ -9.27M£ -4.96M
Interest Expense
--£ 1.73M£ 1.71M£ 974.00K£ 102.00K
EBIT
-£ -16.08M£ -16.08M£ -19.73M£ -8.19M£ -6.23M
EBITDA
-£ -15.19M£ -15.19M£ -19.10M£ -7.53M£ -6.14M
Currency in GBP

Redx Pharma Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis